[HTML][HTML] Management of transfusion-dependent β-thalassemia (TDT): Expert insights and practical overview from the Middle East
A El-Beshlawy, H Dewedar, S Hindawi, S Alkindi… - Blood Reviews, 2024 - Elsevier
Abstract β-Thalassemia is one of the most common monogenetic diseases worldwide, with a
particularly high prevalence in the Middle East region. As such, we have developed long …
particularly high prevalence in the Middle East region. As such, we have developed long …
Thalassaemia—A global view
P Hokland, S Daar, W Khair, S Sheth… - British Journal of …, 2023 - Wiley Online Library
The thalassaemias are a group of genetic disorders of haemoglobin which are endemic in
the tropics but are now found worldwide due to migration. Basic standard of care therapy …
the tropics but are now found worldwide due to migration. Basic standard of care therapy …
Population screening for hemoglobinopathies
HW Goonasekera, CS Paththinige… - Annual review of …, 2018 - annualreviews.org
Hemoglobinopathies are the most common single-gene disorders in the world. Their
prevalence is predicted to increase in the future, and low-income hemoglobinopathy …
prevalence is predicted to increase in the future, and low-income hemoglobinopathy …
Thermogravimetric analysis coupled with chemometrics as a powerful predictive tool for ß-thalassemia screening
R Risoluti, S Materazzi, F Sorrentino, L Maffei… - Talanta, 2016 - Elsevier
Abstract β-Thalassemia is a hemoglobin genetic disorder characterized by the absence or
reduced β-globin chain synthesis, one of the constituents of the adult hemoglobin tetramer …
reduced β-globin chain synthesis, one of the constituents of the adult hemoglobin tetramer …
Familial hypercholesterolemia mutations in the Middle Eastern and North African region: a need for a national registry
MA Bamimore, A Zaid, Y Banerjee, A Al-Sarraf… - Journal of clinical …, 2015 - Elsevier
Background Familial hypercholesterolemia (FH) is a well-understood Mendelian disorder
that increases the risk of cardiovascular disease (CVD), a leading cause of mortality in …
that increases the risk of cardiovascular disease (CVD), a leading cause of mortality in …
Antenatal screening for haemoglobinopathies: current status, barriers and ethics
S Chakravorty, MC Dick - British journal of haematology, 2019 - Wiley Online Library
Sickle cell disease (SCD) and thalassaemia are genetic disorders that are caused by errors
in the genes for haemoglobin and are some of the most common significant genetic …
in the genes for haemoglobin and are some of the most common significant genetic …
[HTML][HTML] Systematic review of outcomes in studies of reproductive genetic carrier screening: Towards development of a core outcome set
Purpose Current practice recommendations support the widespread implementation of
reproductive genetic carrier screening (RGCS). These consensus-based recommendations …
reproductive genetic carrier screening (RGCS). These consensus-based recommendations …
Invasive prenatal diagnosis of fetal thalassemia
DZ Li, YD Yang - Best Practice & Research Clinical Obstetrics & …, 2017 - Elsevier
Thalassemia is the most common monogenic inherited disease worldwide, affecting
individuals originating from many countries to various extents. As the disease requires long …
individuals originating from many countries to various extents. As the disease requires long …
Interventions addressing genetic disease burdens within selected countries in the MENA region: a scoping review
M Grant, T Kabakian-Khasholian, S Yazbek - Journal of Community …, 2023 - Springer
Background The MENA region is disproportionately affected by genetic disease. The aim of
this research is to scope the region for evidence of genetic services and public health …
this research is to scope the region for evidence of genetic services and public health …
Report on ten years' experience of premarital hemoglobinopathy screening at a center in Antalya, Southern Turkey
D Canatan, S Delibas - Hemoglobin, 2016 - Taylor & Francis
Thalassemia and hemoglobinopathies are a major public health problem in Turkey.
Hemoglobinopathy prevention programs (HPPs) were started in 33 provinces situated in …
Hemoglobinopathy prevention programs (HPPs) were started in 33 provinces situated in …